Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 188281 | Arimoclomol maleate | 289893-26-1 | 98% |  |
| Arimoclomol, also known as BRX-220, is potentially useful for the treatment of Nieman | ||||
| 1810163 | BMS-986165 | 1609392-27-9 | >99% |  |
| BMS-986165 potently binds to the Tyk2 pseudokinase domain (Ki = 0.02 nM). BMS-986165 | ||||
| 1810164 | Pemigatinib (INCB054828) | 1513857-77-6 | 98% |  |
| Pemigatinib (INCB054828) is an orally active, selectiveFGFRinhibitor withIC50s of 0.4 | ||||
| 1811121 | DCC-2618 ( Ripretinib ) | 1442472-39-0 | >98% |  |
| Ripretinib, also known as DCC-2618, is a potent, orally active and selective KIT/PDGF | ||||
| 1811162 | PF-05231023 | 1037589-69-7 | >98% |  |
| PF-05231023 is a long-acting FGF21 mimetic. PF-05231023 decreases body weight and imp | ||||
| 5141902 | Avatrombopag maleate | 677007-74-8 | 96% |  |
| Avatrombopag maleate is an orally bioavailable, small molecule thrombopoietin recepto | ||||
| 1811211 | Anlotinib HCl ( AL-3818 ) | 1360460-82-7 | ≧98.0% |  |
| Anlotinib is a novel oral tyrosine kinase inhibitor (TKI) targeting c-kit, platelet-d | ||||
| 19132 | Cilofexor ( GS-9674 ) | 1418274-28-8 | ≧98.0% |  |
| Cilofexor (also known as GS-9674) is a nonsteroidal farnesoid X receptor (FXR) agonis | ||||
| 191122 | Tafenoquine ( WR 238605 ) | 106635-80-7 | ≧98.0% |  |
| Tafenoquine is being investigated as a potential treatment for malaria, as well as fo | ||||
| 191146 | AR-9281 | 913548-29-5 | >98% |  |
| AR-9281 is a soluble epoxide hydrolase (s-EH) inhibitor potentially for the treatment | ||||
| 19356 | AZ876 | 898800-26-5 | >98% |  |
| AZ876, also known as AZ-876, is a liver X receptor agonist. AZ876 protects against pa | ||||
| S510901 | Cenicriviroc Mesylate | 497223-28-6 | 98% Min. |  |
| Cenicriviroc (CVC) is an oral, once-daily, potent immunomodulator that blocks two che | ||||